What is the African Medicines Agency?
Recommendation
27/28 May 2025
Supervision of the Pharmaceutical Quality System: Challenges and Opportunities
Register now for ECA's GMP Newsletter
Under the umbrella of the African Union (AU), the African Medicines Agency (AMA) is currently being established. The African Medicines Regulatory Harmonization (AMRH) programme started already back in 2009 as a response to addressing challenges faced by National Medicine Regulatory Authorities (NMRAs) in Africa like non-coherent legislative frameworks, limited capacities and delayed approval decisions. It seeks to enable collaboration among African countries and regions, to help harmonise the regulation and oversight of medicines at Africa-wide level. To date, 27 countries have ratified the AMA treaty, and more AU members are expected to complete the process in the near future.
The AMA is also supported by the European Medicines Agency and the EU Commission. With the European medicines regulatory network (EMRN), support will be given in the following areas:
- pooling resources and coordinating work to regulate medicines,
- reducing administrative burden,
- mobilising experts to support scientific and administrative processes,
- training to reinforce scientific and regulatory expertise.
The EMA has now received a grant of ten million euros from the European Commission to support regulatory systems at national and regional level in Africa.
Source: EMA press release
Related GMP News
30.04.2025FDA Warning Letter on missing Audit Trails and Raw Data Review
23.04.2025New WHO Guideline Package: TRS 1060 published
16.04.2025EMA: QPs must provide a written final Assessment and Approval of Third-Party Audit Reports
15.04.2025Strategic Report published by the Critical Medicines Alliance
09.04.2025EMA's Plans for the next three Years
09.04.2025Q&A Document on QP Declaration updated